A 68-year-old man with COPD (FEV1 42% predicted) and sleep apnea is admitted for open prostatectomy. Postoperatively, he is prescribed intravenous patient-controlled analgesia (PCA) with morphine. The nursing staff notes that despite adequate pain control, the patient is increasingly somnolent and his oxygen saturation drops to 88% on room air. Which of the following modifications to his PCA regimen is most appropriate to mitigate opioid-induced respiratory depression while maintaining analgesia?

Question

Accepted Answer

C. Switch to a multimodal analgesic approach with reduced opioid requirements, and consider adjuvant agents such as regional anesthesia or NSAIDs. ## Rationale

In a high-risk patient with COPD and sleep apnea, opioid-induced respiratory depression (OIRD) is a serious concern. The clinical scenario describes a patient with declining oxygen saturation and increased somnolence—hallmark signs of opioid toxicity.

### Why Multimodal Analgesia is the Gold Standard:

**Key Point:** Multimodal analgesia reduces opioid consumption by 20–50% while maintaining or improving pain control and reducing opioid-related adverse effects (OIRD, nausea, constipation).

**High-Yield Principle:** In patients at high risk for respiratory depression (COPD, OSA, obesity, renal impairment, advanced age), opioid-sparing techniques are the standard of care:
- **Regional anesthesia** (epidural, peripheral nerve blocks) provides excellent analgesia with minimal systemic opioid exposure.
- **NSAIDs** (ketorolac) reduce opioid requirements by 20–30%.
- **Acetaminophen** (up to 3–4 g/day) is safe and additive.
- **Gabapentinoids** (pregabalin, gabapentin) reduce opioid consumption and neuropathic pain.
- **Dexamethasone** (single perioperative dose) reduces pain and inflammation.

### Why Background Infusions Are Contraindicated:

Background infusions (basal rates) in PCA are **associated with increased risk of OIRD**, especially in opioid-naive patients and those with respiratory compromise. The 2016 American Pain Society and 2018 ASRA guidelines recommend **avoiding basal infusions in opioid-naive patients** because they:
- Eliminate the patient's ability to titrate to their own needs.
- Cause drug accumulation during sleep, increasing respiratory depression risk.
- Increase naloxone rescue requirements.

### Clinical Pearl:

For a post-operative patient with COPD and OSA, the **combination of reduced opioid exposure + regional anesthesia + NSAIDs** is the evidence-based approach. This patient may benefit from:
1. **Epidural analgesia** (if not contraindicated) with local anesthetic ± low-dose opioid.
2. **Peripheral nerve blocks** (e.g., transversus abdominis plane block for prostatectomy).
3. **Multimodal systemic agents** (acetaminophen, NSAIDs, gabapentin).
4. **PCA with NO basal infusion**, lower bolus doses, and longer lockout intervals if opioids are used.

### Why Increasing Bolus/Reducing Lockout Is Dangerous:

This approach **increases opioid delivery** in an already at-risk patient, worsening OIRD.

### Why Intramuscular Injections Are Inferior:

IM morphine:
- Lacks the patient's ability to self-titrate.
- Has unpredictable absorption.
- Increases risk of overdose and under-treatment.
- Is not recommended in modern perioperative pain management guidelines.

Answer

A. Increase the bolus dose and reduce the lockout interval to improve patient satisfaction and pain relief

Answer

B. Add a background infusion of morphine at 2 mg/hour to ensure continuous analgesia and reduce patient effort

Answer

D. Discontinue PCA entirely and switch to intramuscular morphine injections administered by nursing staff at fixed intervals

Explanation

Practice similar questions

Explanation

Practice similar questions